medRxiv preprint doi: https://doi.org/10.1101/2020.04.22.20074898; this version posted April 25, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Non-Linear Fitting of Sigmoidal Growth Curves to predict a maximum limit to the total number of
COVID-19 cases in the United States.
Carlos Maximiliano Dutra – UNIPAMPA, Brazil
carlosdutra@unipampa.edu.br
Abstract
In the present work is used non-linear fitting of the "Gompert" and "Logistic" growth models to the
number of total COVID-19 cases from the United States as a country and individually by states.
The methodology allowed us to estimate that the maximum limit for the total number of cases of
COVID-19 patients such as those registered with the World Health Organization will be
approximately one million and one hundred thousand cases to the United States. Up to 04/19/20 the
models indicate that United States reached 70% of this maximum number of "total cases" and the
United States will reach 95% of this limit by 05/14/2020. The application of the nonlinear fitting of
growth curves to the individual data of each American state showed that only 25% of them did not
reach, on 04/19/20, the percentage of 59% of the maximum limit of "total cases" and that 17 of the
50 states still will not have reached 95% of that limit on 05/14/20.
key-words: covid19; coronavirus; gompertz; logistic; model; united states; US; epidemiology
Introduction
The first case of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection
appeared in the Hubei Province in China on December 31, 2019, as reported by the World Health
Organization - WHO (SR1, 2020). According to Chan et al. (2020) in february WHO officially
called the disease caused by SARS-CoV-2 of COVID-19 (Coronavirus Dease 2019) and on 11
march the COVID-19 was classified as a Pandemic.
In the United States, the first case of COVID19 was registered on January 10, 2020 and by
April 20, 2020, 792,759 total cases, +28,123 new cases and 42,514 deaths had been registered
(https://www.worldometers.info/coronavirus/ ). For the United States according to the
“...CDC case counts and death counts include boh confirmed and probable cases and deaths. “
(CDC, 2000). Daily statistics on the number of new cases, total cases and deaths have been the
main variables for controlling the impact of COVID19 on society and especially on the capacity of
the hospital health system to take into account the number of critical cases. The real impact of
COVID19 in the world will hardly be known as there are many asymptomatic cases and we have
limitations in the ability to carry out tests to confirm this disease, although the United States was the
country that performed the most tests 4,026,360 however it reached 12,164 per 1 million people, as
data from April 20, 2020 (https://www.worldometers.info/coronavirus/country/us/).
Several researchers have presented models to predict the evolution of the number of cases of
infected by COVID19. Bliznashki (2020) applied a Bayesian Logistic Growth model to the
COVID-19 data cases in the period between 4 th of March and 31th of March and found that the data
in this interval have small number of available data points without upper asymptote to can be well
fitted by this model, but it will be useful with more actualizated data. Mondal and Ghosh (2020)
studied the scenarios of the exponential and sigmoid growth of COVID-19 total cases data for 15
NOTE:
preprint
reports new research
that has
not been certified
by peer review
should not be usedwith
to guide a
clinical
practice.
states
of This
India
considering
a initial
exponential
growth
and and
a extrapolation
sigmoid-type
profile. Peirlinck et al. (2020) estimated to the United States the nationwide peak of the outbreak

medRxiv preprint doi: https://doi.org/10.1101/2020.04.22.20074898; this version posted April 25, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

on May 10, 2020 with 3 million infections across the United States.
In the present work we propose the use of non-linear adjustment of sigmoidal growth
functions together with the total case data to estimate maximum limits for the number of total cases
of COVID19 in the United States.
Metodology and Results
In order to predicted the maximum limit to the total cases COVID19 in the states of US was
applyed to the data of cummulative cases a non-linear fitting of the Sigmoidal growth curves that
are mathematical solutions to the infected cases growing models. According to Teleken et al.
(2017):
The growth functions can be grouped into three models main categories: those with a diminishing
returns behavior (Brody model), those with sigmoidal shape and a fixed inflection point (Gompertz,
Logistic and von Bertalanffy models) and those with a flexible inflection point (Richards model). The
Logistic, Gompertz and von Bertalanffy models exhibit inflection points at about 50, 37 and 30% of
the mature weight (asymptote), respectively. On the other hand, the Brody model does not exhibit an
inflection point.

Sigmoid growth curves have been used to estimate the time evolution of total cases, daily
cases and deaths for countries like Iran (Ahmadi et al. 2020) and China, Italy and Germany
(Mimkes & Janssen 2020). This work will be carried out the non-linear fitting to the cummulative
cases COVID-19 using Gompertz and Logistic models. The matemathical functions used were:
Gompertz Model:

−e

N (t)=ae

−( k ( t−ti))

, where “a”, “k”, and “ti” are empirical parameters.

Logistic Model:

N (t )=a÷(1+e−( k (t−ti )))

, where “a”, “k”, and “ti” are empirical parameters.

The parameter “a” gives the maximum limit to the total cases, the parameter “k” is related to
the growth rate and “ti” corresponds to the inflection time coordinate.
The performance of each model was evaluated by Residual Sum Square (RSS) and two
additional criteria based on the information theory were applied to compare the goodness of fit of
the models (Burnham & Anderson, 2002): the Akaike information criterion (AIC) and the Bayesian
information criterion (BIC).
Results and discussion
First was performed non-linear fitting of Gompertz and Logistic models to the data of
cummulative cases COVID19 of Hubei (China), South Korea and US, available in the site
https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases . and was obtain the results
shown in Table 1. The Logistic Model give better goodness fit to the Hubei(China), while Gompertz
model adjusted better the data from South Korea and United States. In sequence, Table 1 presents
the fitting results for the states of the United States, which the data were obtained in the site
https://github.com/nytimes/covid-19-data/blob/master/us-states.csv . Although for the US data the

medRxiv preprint doi: https://doi.org/10.1101/2020.04.22.20074898; this version posted April 25, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

best fit model was the Gompertz, considering individual fits for 14 of the 50 american states the
best fit model were the logistic. The data considered to fit were up to 04/17/20, and the best fit
models have the parameters in bold.

Table 1. Results of Non-linear fitting from total cases COVID19 data up to 04/17/20.
Gompertz Model
Country

a

xc

k

Hubei, China

68244,1

16,8

0,16 3,99E+008

Korea South

10125,85

40,13 0,13 1,01E+007

US

1122702,72 77,47 0,08 1,92E+008

Logistic Model

RSS

AIC

BIC

a

ti

k

RSS

AIC

1343,16 1352,54

67769,03

19,7

0,23

2,37E+008

1297,49 1306,86

1023,3

9854,84

43,05

0,2

1,95E+007

1080,21 1089,58

782563,95

76,72

0,18

3,22E+009

1524,59 1533,97

1032,67

1279,21 1288,59

BIC

States of United States
State

a

xc

AIC

BIC

a

ti

k

RSS

AIC

BIC

Alabama

11199,17

33,69 0,06 127491,34

k

RSS

303,49

308,54

5925,79

28,69

0,17

147477,47

308,73

313,78

Alaska

393,48

21,49 0,09 1060,13

133,39

138,59

323,55

23,01

0,17

1915,66

170,83

176,02

Arizona

6434,3

38,85 0,08 80404,14

378,03

384,79

4787,57

38,99

0,19

319241,13

446,97

453,73

Arkansas

3333,42

31,23 0,06 29156,96

261,64

266,98

2076,76

28,43

0,14

64365,31

291,73

297,07

Califórnia

45872,93

73,58 0,08 2299549,23

866,77

875,98

32541,15

73,05

0,17

4855789,13

929,55

938,77

Colorado

13395,26

32,39 0,08 294629,74

396,63

402,74

9861,07

32,4

0,17

1252439,33

460,31

466,42

Connecticut

34734,72

36,59 0,07 771814,01

412,67

418,41

20362,07

33,59

0,19

15578364,85 442

447,74

Delaware

6482,66

38,41 0,06 50986,99

282,88

288,22

2984,41

32,11

0,19

24517,76

255,05

260,39

Columbia*

5534,65

38,47 0,06 44338,19

301,48

307,35

3027,89

34,1

0,17

32426,87

288,34

294,21

Florida

33764,86

36,05 0,09 820812,24

476,78

483,33

26104,57

36,64

0,2

5220809,16

565,58

572,14

Georgia

28059,52

38,89 0,07 2874350,97

526,94

533,4

18634,22

37,48

0,18

3879116,33

541,04

547,49

Guam*

1160,87

24,78 0,12 52768,22

259,19

263,91

888,91

25,1

0,27

33610,01

243,85

248,58

Hawaii

654,88

26,17 0,1

187,01

193,01

559,28

27,89

0,2

1526,09

162,53

168,52

Idaho

1594,27

18,89 0,19 58184,48

275,25

280,29

1500,56

20,6

0,32

53463,26

272,21

277,25

Illinois

57349,97

80,4

0,07 613843,53

763,71

772,98

33463,51

77,07

0,17

3898019,14

920,83

930,1

Indiana

14821,53

33,07 0,09 179034,27

367,42

373,41

10914,07

33,08

0,2

964801,91

439,85

445,84

Iowa

7672,64

44,88 0,05 13460,98

246,66

252,41

3254,77

35,83

0,15

44410,58

295,6

301,35

Kansas

2770,03

33,06 0,08 12566,67

248,53

254,4

1904,09

32,13

0,18

27775,92

281,84

287,71

Kentucky

5768,24

39,57 0,06 34454,74

296,56

302,55

3186,01

35,31

0,17

38643,21

301,49

307,48

Louisiana

26184,18

25,41 0,15 305406,99

511,2

516,81

23255,05

27,01

0,27

4386832,21

473,35

478,96

Maine

1240,53

24,96 0,07 8906,1

212,14

217,33

903,07

24,79

0,15

18660,84

239,51

244,7

Maryland

29483,08

42,91 0,07 704619,75

435

441,11

14766,82

37,8

0,19

481112,85

418,21

424,32

Massachussets 86495,04

75,77 0,06 3969635,04

844,03

852,85

44559,52

70,56

0,17

1,04E+007

918,21

927,03

Michigan

38301,45

26,06 0,11 2376608,87

438,86

444,34

31026,27

27,09

0,22

6424144,33

477,64

483,12

Minnesota

5831,74

44,3

286,77

292,76

2774,94

36,1

0,13

67940,82

325,76

331,75

Mississippi

9580,03

36,85 0,05 60051,03

289,1

294,43

4949,3

31,01

0,15

194556,43

333,77

339,1

Missouri

7744,96

31,32 0,09 72905,86

322,37

328,24

5771,46

31,48

0,2

321060,88

384,63

390,5

Montana

463,77

17,64 0,12 986,28

128,46

133,51

418,9

19,75

0,22

2550,14

162,66

167,71

Nebraska

19949,46

97,46 0,03 10931,24

325,21

332,94

2285,38

60,46

0,14

7759,51

304,31

312,04

Nevada

5039,34

31,93 0,08 30529,53

296,88

302,99

3791,19

32,23

0,18

144881,65

365,4

371,51

New
Hampshire

1971,13

36,78 0,07 14543,43

278,48

284,93

1391,82

36,19

0,17

28280,37

309,74

316,19

New Jersey

113272,31

34,34 0,09 9289561,43

559,7

565,92

84799,07

34,55

0,2

7,24E+007

652,09

658,32

New Mexico

4531,08

37,55 0,06 12127,37

228,31

233,64

2199,88

31,36

0,17

7631,16

210,7

216,04

New York

340941,99

36,3

708,39

714,94

251484,83

36,34

0,17

7,64E+008

804,91

811,46

2696,91

0,04 27440,57

0,08 1,02E+008

medRxiv preprint doi: https://doi.org/10.1101/2020.04.22.20074898; this version posted April 25, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

North
Carolina

10439,31

38,59 0,07 83665,4

354,24

360,59

6731

36,71

0,17

281144,65

410

416,34

North Dakota

782,81

31,08 0,06 2687,29

171,04

176,38

493,62

28,63

0,15

5316,08

196,97

202,3

Ohio

15785,09

32,66 0,07 460996,81

383,23

388,84

10270,33

30,91

0,17

1442560,39

428,86

434,48

Oklahoma

3317,6

31,1

286

291,99

2595,19

31,79

0,21

72332,65

328,45

334,44

Oregon

2430,03

35,96 0,08 11854,37

282,31

289,07

1901,56

36,78

0,17

28816,92

326,72

333,48

Pennsylvania

33453,22

34,15 0,21 2963144,25

476,49

482,48

33453,22

34,15

0,21

2963144,25

488,1

494,09

Puerto Rico*

1553,21

25,81 0,1

202,05

228,59

1174,75

26,13

0,21

15918,41

228,59

233,64

Rhode Island

36532,64

65,81 0,04 113132,08

381,65

388,21

6957,21

45,78

0,19

55548,44

347,51

354,06

Sourh
Carolina

5844,49

31,56 0,09 84398,48

335,08

341,07

4378,93

31,77

0,19

129010,5

353,33

359,32

South Dakota

21496

64,37 0,04 28939

223,43

228,91

2889,7

39,33

0,19

13652

209,22

214,69

Teneessee

8599,3

30,79 0,09 243574,75

388,26

394,37

6700,53

31,53

0,18

737350,93

437

443,11

Texas

33120,41

59,38 0,07 1274303,81

659,96

668,06

20979,67

57,39

0,19

1,26E+006

659,27

667,37

Utah

3842,86

40,19 0,08 37097,35

356,04

363,08

2945,26

40,7

0,18

8,26E+004

398,48

405,53

Vermont

989,04

26,46 0,1

239,56

245,43

831,15

28,02

0,2

6,51E+003

220,9

226,77

Virginia

18998,42

40,96 0,06 120044,57

343,31

349,18

9587,79

35,61

0,18

2,01E+005

365,06

370,93

Washington

14714,5

70,55 0,08 1948290,21

888,93

898,36

12023,21

72,02

0,17

724686,95

801,9

811,33

West Virginia

1297,2

23,59 0,08 6419,71

179,13

183,51

885,66

22,64

0,2

5223,5

172,53

176,91

Wisconsin

5763,44

60,24 0,08 34957,12

459,1

467,67

4325,38

60,51

0,18

181686,31

579,42

587,99

Wyoming

369,85

21,85 0,1

139,27

144,61

311,66

23,42

0,2

630,95

115,98

121,32

0,1

26953,48

7616,16

10151,68

1164,56

* In addition to the 50 states, two territories Guam and Puerto Rico and the district of Columbia
were included.
Defined the best model to adjust the total case data, the model predictions were made using
the parameters “a” to define the maximum of the total cases and the other empirical parameters and
the mathematical functions to make temporal predictions for the data observed on 4/19/20 and the
determination of the dates on which 95% and 99% of the maximum total cases will be reached,
according to Table 2. Model forecasts were made for Hubei (China) and South Korea, which are
already in the stable control phase of COVID19 and the results of the total number of cases in the
model adjusted well to the data of total cases observed on April 19, 2020 (comparing the predicted
cases with those observed and verifying the low relative error value). The maximum percentage
reached according to the model for that date was also estimated, as well as the forecast of dates
when according to the model a percentage of 95% and 99%, respectively, of the maximum value of
the total cases predicted in the model are reached. For the total case data from the United States, we
had the Gompertz model as the best fit, from which we have an estimated maximum for the total
MAX_Cases cases of 1,122,702.72. For April 19, 2020, the comparison between the number of
cases predicted by the model and those observed results in a relative error of -0.62% and on this day
the total number of cases predicted by the model corresponds to a percentage of 67, 19% in relation
to the maximum of MAX_Cases total cases. Finally, the model predicts that the United States will
reach 95% of the maximum total number of cases on 5/14/20 and 99% on 6/4/20.

Table 2. Predictions for the “total cases” data.
Predictions 04/19/20
Country

Model

MAX_Cases

Predicted Cases

Observed
Cases

Relative
Error(%)

Pr_max (%)

Date 95% Date 99%

Hubei, China

L

67769,03

67769,02

68128

-0,53

99,99

02/22/20

02/29/20

Korea South

G

10125,85

10108,23

10661

-5,18

99,83

03/24/20

04/05/20

US

G

1122702,72

754405,83

759086

-0,62

67,19

05/14/20

06/04/20

medRxiv preprint doi: https://doi.org/10.1101/2020.04.22.20074898; this version posted April 25, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Predictions 04/19/20
State

Model

MAX_Cases

Predicted Cases

Observed
Cases

Relative
Error(%)

Pr_max (%)

Date 95% Date 99%

Alabama

G

11199,17

5174,32

4903

5,53

46,2

06/03/20

06/30/20

Alaska

G

393,48

319,96

317

0,93

81,32

05/04/20

05/22/20

Arizona

G

6434,3

4537,63

4929

-7,94

70,52

05/13/20

06/06/20

Arkansas

G

3333,42

1846,24

1781

3,66

55,39

05/30/20

06/25/20

Califórnia

G

45872,93

31678,36

31544

0,43

69,06

05/14/20

06/03/20

Colorado

G

13395,26

9566,63

9730

-1,68

71,42

05/12/20

02/01/20

Connecticut

G

34734,72

18343,63

17962

2,12

52,81

05/25/20

06/17/20

Delaware

L

2984,41

2439,58

2538

-3,87

81,74

04/26/20

05/05/20

Columbia

L

3027,89

2553,42

2793

-8,58

84,33

04/26/20

05/06/20

Florida

G

33764,86

25393,35

26306

-3,47

75,21

05/08/20

05/26/20

Georgia

G

28059,52

17142,34

17619

-2,7

61,09

05/21/20

06/13/20

Guam

L

888,91

844,4

808

4,51

94,99

04/19/20

04/25/20

Hawaii

L

559,28

541,6

574

-5,64

96,84

04/16/20

04/24/20

Idaho

L

1500,56

1494,85

1581

-5,44

99,62

04/10/20

04/15/20

Illinois

G

57349,97

30543,44

30357

0,61

53,26

05/25/20

06/17/20

Indiana

G

14821,53

10531,17

11210

-6,06

71,05

05/10/20

05/28/20

Iowa

G

7672,64

2557,68

2915

-12,26

33,33

06/19/20

07/21/20

Kansas

G

2770,03

1825,91

1898

-3,8

65,92

05/15/20

06/04/20

Kentucky

G

5768,24

2802,23

2960

-5,32

48,58

06/02/20

06/29/20

Louisiana

L

23255,05

22855,77

23928

-4,48

98,28

04/15/20

04/21/20

Maine

G

1240,53

853,23

867

-1,59

68,77

05/17/20

06/09/20

Maryland

L

14766,82

12198,37

12830

-4,92

82,61

04/26/20

05/05/20

Massachussets

G

86495,04

37949,81

38077

-0,33

43,87

06/04/20

07/01/20

Michigan

G

38301,45

31568,7

31348

0,7

82,42

05/01/20

05/15/20

Minnesota

G

5831,74

2205,44

2356

-6,39

37,82

07/02/20

08/11/20

Mississippi

G

9580,03

4077,17

4274

-4,6

42,55

06/14/20

07/16/20

Missouri

G

7744,96

5627,17

5667

-0,7

72,66

05/09/20

05/27/20

Montana

G

463,77

425,17

433

-1,81

91,68

04/23/20

05/07/20

Nebraska

L

2285,38

1343,75

1474

-8,84

58,8

05/07/20

05/19/20

Nevada

G

5039,34

3643,04

3741

-2,62

72,29

05/12/20

06/01/20

New Hampshire G

1971,13

1288,52

1392

-7,43

65,37

05/19/20

06/11/20

New Jersey

G

113272,31

74064,52

85301

-13,17

65,39

05/15/20

06/04/20

New Mexico

L

4531,08

1788,23

1845

-3,08

81,29

04/27/20

05/07/20

New York

G

340941,99

244082,7

242817

0,52

71,59

05/12/20

06/01/20

North Carolina

G

10439,31

6221,77

6493

-4,18

59,6

05/22/20

06/14/20

North Dakota

G

782,81

435,87

585

-25,49

55,68

05/30/20

06/25/20

Ohio

G

15785,09

9383,94

11602

-19,12

59,45

05/22/20

06/14/20

Oklahoma

G

3317,6

2586,14

2599

-0,49

77,95

05/05/20

05/21/20

Oregon

G

2430,03

1841,82

1910

-3,57

75,79

05/10/20

05/30/20

Pennsylvania

G

33453,22

30196,02

32992

-8,47

90,26

04/22/20

04/30/20

Puerto Rico

G

1553,21

1155,81

1213

-4,71

74,41

05/06/20

05/22/20

Rhode Island

G

6957,21

4442,68

4706

-5,59

63,86

04/30/20

05/09/20

South Carolina

G

5844,49

4337

4377

-0,91

74,21

05/08/20

05/26/20

South Dakota

L

2889,7

1672,17

1635

2,27

57,86

05/03/20

05/11/20

Teneessee

G

8599,3

6667,83

6845

-2,59

77,54

05/07/20

05/24/20

Texas

L

20979,67

18513,64

19443

-4,77

88,24

04/24/20

05/02/20

medRxiv preprint doi: https://doi.org/10.1101/2020.04.22.20074898; this version posted April 25, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Utah

G

3842,86

2830,37

3071

-7,83

73,65

05/11/20

05/31/20

Vermont

L

831,15

798,47

812

-1,67

96,07

04/17/20

04/26/20

Virginia

G

18998,42

8257,21

8537

-3,28

43,46

06/04/20

07/01/20

Washington

L

12023,21

11482,97

11805

-2,73

95,51

04/18/20

04/28/20

West Virginia

L

885,66

802,88

890

-9,79

90,65

04/22/20

04/30/20

Wisconsin

G

5763,44

4239,74

4346

-2,44

73,56

05/11/20

05/31/20

Wyoming

L

311,66

300,74

313

-3,92

96,5

04/17/20

04/25/20

TOTAL

1085939,78

Note: in the “model” column letter “L” designate Logistic ande letter “G” designate Gompertz.

Considering the COVID19 total case data from the states (plus Columbia, Guam and Puerto
Rico) in the United States, the following results were summarized in Table 2:
(a) limit for the maximum total cases for the United States of 1,085,939.78, which is approximately
3% less than the predicted total considering the data for the United States as a whole; (b) Only 25%
of the states had a relative error greater than 6%, the average relative error in module was 4.90% for
the value of "total cases" on 04/19/20; (c) Only 25% of the states reached less than 59% of the
maximum value of "total cases" on 04/19/20; (d) Until 05/14/2020, only 17 of the 50 American
states will not have reached 95% of the maximum limit of the "total cases".
Final considerations
The non-linear fitting of growth functions to the data on the total number of COVID-19
cases is a useful tool to estimate the duration and impact of this pandemic, and may become
increasingly accurate as the history of the disease evolves. This study demonstrates the importance
of carrying out the COVID-19 tests for understanding the future of the development of this
pandemic, only with precise and actualizated statistics will be possible to prepare the health system
to the demand.

References
Ahmadi, A., Fadaei, Y., Shirani, M., Rahmani, F. Modeling and Forecasting Trend of COVID-19
Epidemic in Iran until May 13, 2020. 2020. Cold Spring Harbor Laboratory Press.
https://www.medrxiv.org/content/10.1101/2020.03.17.20037671v3
Bliznashki, S. A Bayesian Logistic Growth Model for the Spread of COVID-19 in New York. 2020.
Cold Spring Harbor Laboratory Press.
https://www.medrxiv.org/content/10.1101/2020.04.05.20054577v2.full.pdf
Burnham, K. P., & Anderson, D. R. (2002). Model selection and multimodel inference: a practical
information-theoretic approach. New York City, NY: Springer-Verlag.
CDC. Standardized surveillance case definition and national notification for 2019 novel coronavirus
disease (COVID-19) . (2020) https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-inus.html
Chan, J.F.W. et al. A familial cluster of pneumonia associates with the 2019 novel coronavirus
indicating person-to-person transmission: a study of a family cluster. The Lancet, v. 395, m. 10223,
p. 514-523. 2020.
Miller, F., Becker, A. D., Grenfell, B. T., Metcalf, C. J. Mapping the Burden of COVID-19 in the
United States. 2020. Cold Spring Harbor Laboratory Press
https://www.medrxiv.org/content/early/2020/04/11/2020.04.05.20054700.full.pdf
Mimkes, J.; Janssen, R. On the corona infection model with contact restriction. 2020. Cold Spring
Harbor Laboratory Press. https://www.medrxiv.org/content/10.1101/2020.04.08.20057588v1

medRxiv preprint doi: https://doi.org/10.1101/2020.04.22.20074898; this version posted April 25, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Mondal, S.; Ghosh, S. Possibilities of exponential or Sigmoid growth of Covid19 data in different
states of India. 2020. Cold Spring Harbor Laboratory Press.
https://www.medrxiv.org/content/10.1101/2020.04.10.20060442v1.full.pdf
Peirlinck, M., Costabal, F., Linka, K., Kuhl, E. Outbreak dynamics of COVID-19 in China and the
United States. 2020. Cold Spring Harbor Laboratory Press.
https://www.medrxiv.org/content/early/2020/04/11/2020.04.06.20055863.full.pdf
Pongkitivanichkul, C., Samart, D., Tangphati, T., Koomhin, P. , Pimton, P., Dam-o, P., Payaka, P.,
Channuie, A. Estimating the size of COVID-19 epidemic outbreak. 2020 doi:
https://doi.org/10.13140/RG.2.2.29866.36808
World Health Organization. Novel Coronavirus (2019- nCoV) Situation Report – 1. Janeiro 2020.
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019ncov.pdf?sfvrsn=20a99c10_4

